|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,257.00 ILa | -0.27% |
|
+5.76% | -0.13% |
| 06-01 | Kamada Announces FDA Approval of Its New In-House Rabies Virus Neutralization Testing Laboratory | CI |
| 05-13 | Kamada Ltd., Q1 2026 Earnings Call, May 13, 2026 |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bearish | Bearish |
| Resistance | 2,319 | 2,500 | 2,494 |
| Spread/Res. | -2.67% | -9.72% | -9.50% |
| Spread/Supp. | +6.51% | +6.51% | +6.51% |
| Support | 2,119 | 2,119 | 2,119 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- KMDA Stock
- Charts Kamada Ltd.
Select your edition
All financial news and data tailored to specific country editions
